Innate immunity networks during infection with Borrelia burgdorferi

Critical Reviews in Microbiology

Volumn 42, Issue 2, 2016, Pages 233-244

  Oosting, Marije ^a   Buffen, Kathrin ^a   Van Der Meer, Jos W M ^a   Netea, Mihai G ^a   Joosten, Leo A B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; Lyme disease; pattern recognition receptors; recognition

Indexed keywords

COMPLEMENT; CRYOPYRIN; INFLAMMASOME; INTERFERON; INTERLEUKIN 1; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; OUTER SURFACE PROTEIN A; PATTERN RECOGNITION RECEPTOR; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; CYTOKINE;

ANTIGEN RECOGNITION; BACTERIAL VIRULENCE; BORRELIA BURGDORFERI; COMPLEMENT ACTIVATION; CYTOKINE PRODUCTION; HELPER CELL; HOST RESISTANCE; HUMAN; INNATE IMMUNITY; LYME DISEASE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM; IMMUNOLOGY; IMMUNOMODULATION; METABOLISM; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; BORRELIA BURGDORFERI; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; IMMUNITY, INNATE; IMMUNOMODULATION; INFLAMMASOMES; LYME DISEASE; RECEPTORS, PATTERN RECOGNITION; SIGNAL TRANSDUCTION;

EID: 84959272565     PISSN: 1040841X     EISSN: 15497828     Source Type: Journal    
DOI: 10.3109/1040841X.2014.929563     Document Type: Review

References (123)

1. Akira S, Takeda K. (2004). Toll-like receptor signalling. Nat Rev Immunol 4:499-511.
2. Alexopoulou L, Thomas V, Schnare M, et al. (2002). Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in. Nat Med 8:878-84.
3. Anguita J, Barthold SW, Persinski R, et al. (2002). Murine Lyme arthritis development mediated by p38 mitogen-activated protein kinase activity. J Immunol 168:6352-7.
4. Bachmann M, Horn K, Rudloff I, et al. (2010). Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1. PLoS Pathog 6:e1001144.
5. Beck G, Benach JL, Habicht GS. (1990). Isolation, preliminary chemical characterization, and biological activity of Borrelia burgdorferi peptidoglycan. Biochem Biophys Res Commun 167:89-95.
6. Beck G, Habicht GS, Benach JL, et al. (1986). A role for interleukin-1 in the pathogenesis of Lyme disease. Zentralbl Bakteriol Mikrobiol Hyg A 263:133-6.
7. Behera AK, Hildebrand E, Bronson RT, et al. (2006). MyD88 deficiency results in tissue-specific changes in cytokine induction and inflammation in interleukin-18-independent mice infected with Borrelia burgdorferi. Infect Immun 74:1462-70.
8. Behera AK, Thorpe CM, Kidder JM, et al. (2004). Borrelia burgdorferiinduced expression of matrix metalloproteinases from human chondrocytes requires mitogen-activated protein kinase and Janus kinase/signal transducer and activator of transcription signaling pathways. Infect Immun 72:2864-71.
9. Benach JL, Fleit HB, Habicht GS, et al. (1984). Interactions of phagocytes with the Lyme disease spirochete: role of the Fc receptor. J Infect Dis 150:497-507.
10. Bolz DD, Sundsbak RS, Ma Y, et al. (2004). MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J Immunol 173:2003-10.
11. Breitner-Ruddock S, Wurzner R, Schulze J, Brade V. (1997). Heterogeneity in the complement-dependent bacteriolysis within the species of Borrelia burgdorferi. Med Microbiol Immunol 185:253-60.
12. Brown JP, Zachary JF, Teuscher C, et al. (1999). Dual role of interleukin- 10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun 67:5142-50.
13. Bulut Y, Faure E, Thomas L, et al. (2001). Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Tolllike receptor 2 signaling. J Immunol 167:987-94.
14. Burchill MA, Nardelli DT, England DM, et al. (2003). Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi. Infect Immun 71:3437-42.
15. Burgdorfer W, Barbour AG, Hayes SF, et al. (1982). Lyme disease-a tickborne spirochetosis? Science 216:1317-19.
16. Cabral ES, Gelderblom H, Hornung RL, et al. (2006). Borrelia burgdorferi lipoprotein-mediated TLR2 stimulation causes the down-regulation of TLR5 in human monocytes. J Infect Dis 193: 849-59.
17. Cadavid D, O'Neill T, Schaefer H, Pachner AR. (2000). Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of lyme disease. Lab Invest 80:1043-54.
18. Cervantes JL, Dunham-Ems SM, La Vake CJ, et al. (2011). Phagosomal signaling by Borrelia burgdorferi in human monocytes involves Toll-like receptor (TLR) 2 and TLR8 cooperativity and TLR8-mediated induction of IFN-beta. Proc Natl Acad Sci USA 108:3683-8.
19. Cervantes JL, La Vake CJ, Weinerman B, et al. (2013). Human TLR8 is activated upon recognition of Borrelia burgdorferi RNA in the phagosome of human monocytes. J Leukoc Biol 94:1231-41.
20. Charon NW, Cockburn A, Li C, et al. (2012). The unique paradigm of spirochete motility and chemotaxis. Annu Rev Microbiol 66:349-70.
21. Cinco M, Cini B, Murgia R, et al. (2001). Evidence of involvement of the mannose receptor in adhesion of Borrelia burgdorferi to monocyte/macrophages. Infect Immun 69:2743-7.
22. Cinco M, Panfili E, Presani G, Perticarari S. (2000). Interaction with Borrelia burgdorferi causes increased expression of the CR3 integrin and increased binding affinity to fibronectin via CR3. J Mol Microbiol Biotechnol 2:575-9.
23. Codolo G, Amedei A, Steere AC, et al. (2008). Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. Arthritis Rheum 58:3609-17.
24. De Taeye SW, Kreuk L, Van Dam AP, et al. (2013). Complement evasion by Borrelia burgdorferi: it takes three to tango. Trends Parasitol 29: 119-28.
25. Dennis VA, Dixit S, O'Brien SM, et al. (2009). Live Borrelia burgdorferi spirochetes elicit inflammatory mediators from human monocytes via the Toll-like receptor signaling pathway. Infect Immun 77:1238-45.
26. Eberle F, Sirin M, Binder M, Dalpke AH. (2009). Bacterial RNA is recognized by different sets of immunoreceptors. Eur J Immunol 39: 2537-47.
27. Ekerfelt C, Ernerudh J, Bunikis J, et al. (1997). Compartmentalization of antigen specific cytokine responses to the central nervous system in CNS borreliosis: secretion of IFN-gamma predominates over IL-4 secretion in response to outer surface proteins of Lyme disease Borrelia spirochetes. J Neuroimmunol 79:155-62.
28. Ferwerda B, Ferwerda G, Plantinga TS, et al. (2009). Human dectin-1 deficiency and mucocutaneous fungal infections. N Engl J Med 361: 1760-7.
29. Fikrig E, Narasimhan S, Neelakanta G, et al. (2009). Toll-like receptors 1 and 2 heterodimers alter Borrelia burgdorferi gene expression in mice and ticks. J Infect Dis 200:1331-40.
30. Fraser CM, Casjens S, Huang WM, et al. (1997). Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi. Nature 390:580-6.
31. Garcia RC, Murgia R, Cinco M. (2005). Complement receptor 3 binds the Borrelia burgdorferi outer surface proteins OspA and OspB in an iC3b-independent manner. Infect Immun 73:6138-42.
32. Georgilis K, Noring R, Steere AC, Klempner MS. (1991). Neutrophil chemotactic factors in synovial fluids of patients with Lyme disease. Arthritis Rheum 34:770-5.
33. Giambartolomei GH, Dennis VA, Lasater BL, Philipp MT. (1999). Induction of pro- and anti-inflammatory cytokines by Borrelia burgdorferi lipoproteins in monocytes is mediated by CD14. Infect Immun 67:140-7.
34. Glickstein LJ, Coburn JL. (2006). Short report: association of macrophage inflammatory response and cell death after in vitro Borrelia burgdorferi infection with arthritis resistance. Am J Trop Med Hyg 75:964-7.
35. Gringhuis SI, Den DJ, Litjens M, et al. (2009). Dectin-1 directs T helper cell differentiation by controlling noncanonical NF-kappaB activation through Raf-1 and Syk. Nat Immunol 10:203-13.
36. Grusell M, Widhe M, Ekerfelt C. (2002). Increased expression of the Th1-inducing cytokines interleukin-12 and interleukin-18 in cerebrospinal fluid but not in sera from patients with Lyme neuroborreliosis. J Neuroimmunol 131:173-8.
37. Guyard C, Battisti JM, Raffel SJ, et al. (2006). Relapsing fever spirochaetes produce a serine protease that provides resistance to oxidative stress and killing by neutrophils. Mol Microbiol 60:710-22.
38. Hammerschmidt C, Hallstrom T, Skerka C, et al. (2012). Contribution of the infection-associated complement regulator-acquiring surface protein 4 (ErpC) to complement resistance of Borrelia burgdorferi. Clin Dev Immunol 2012:338-45.
39. Hawley KL, Olson Jr CM, Iglesias-Pedraz JM, et al. (2012). CD14 cooperates with complement receptor 3 to mediate MyD88-independent phagocytosis of Borrelia burgdorferi. Proc Natl Acad Sci USA 109:1228-32.
40. Henningsson AJ, Tjernberg I, Malmvall BE, et al. (2011). Indications of Th1 and Th17 responses in cerebrospinal fluid from patients with Lyme neuroborreliosis: a large retrospective study. J Neuroinflammation 8:36.
41. Hirschfeld M, Ma Y, Weis JH, et al. (2000). Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 165:618-22.
42. Hovius JW, De Jong MA, Den DJ, et al. (2008). Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilization. PLoS Pathog 4:e31.
43. Isogai H, Kimura K, Hayashi S, et al. (1997). Levels of endogenous interleukin-1, interleukin-6, and tumor necrosis factor in congenic mice infected with Borrelia garinii. Microbiol Immunol 41:427-30.
44. Jacobson AC, Ma Y, Zachary JF, et al. (2007). Mice lacking CD21 and CD35 proteins mount effective immune responses against Borrelia burgdorferi infection. Infect Immun 75:2075-8.
45. Jones KL, Muellegger RR, Means TK, et al. (2008). Higher mRNA levels of chemokines and cytokines associated with macrophage activation in erythema migrans skin lesions in patients from the United States than in patients from Austria with Lyme borreliosis. Clin Infect Dis 46:85-92.
46. Kang I, Barthold SW, Persing DH, Bockenstedt LK. (1997). T-helpercell cytokines in the early evolution of murine Lyme arthritis. Infect Immun 65:3107-11.
47. Kariko K, Buckstein M, Ni H, Weissman D. (2005). Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23:165-75.
48. Kato H, Takahasi K, Fujita T. (2011). RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol Rev 243:91-8.
49. Kawai T, Akira S. (2009). The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21:317-37.
50. Kenedy MR, Akins DR. (2011). The OspE-related proteins inhibit complement deposition and enhance serum resistance of Borrelia burgdorferi, the Lyme disease spirochete. Infect Immun 79:1451-7.
51. Kenedy MR, Vuppala SR, Siegel C, et al. (2009). CspA-mediated binding of human factor H inhibits complement deposition and confers serum resistance in Borrelia burgdorferi. Infect Immun 77: 2773-82.
52. Kerr JR. (1999). Cell adhesion molecules in the pathogenesis of and host defence against microbial infection. Mol Pathol 52:220-30.
53. Kraiczy P, Hartmann K, Hellwage J, et al. (2004). Immunological characterization of the complement regulator factor H-binding CRASP and Erp proteins of Borrelia burgdorferi. Int J Med Microbiol 293(Suppl 37):152-7.
54. Kraiczy P, Skerka C, Kirschfink M, et al. (2001). Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int Immunopharmacol 1:393-401.
55. Krupka M, Masek J, Bartheldyova E, et al. (2012). Enhancement of immune response towards non-lipidized Borrelia burgdorferi recombinant OspC antigen by binding onto the surface of metallochelating nanoliposomes with entrapped lipophilic derivatives of norAbuMDP. J Control Release 160:374-81.
56. Kumru OS, Bunikis I, Sorokina I, et al. (2011). Specificity and role of the Borrelia burgdorferi CtpA protease in outer membrane protein processing. J Bacteriol 193:5759-65.
57. Kuo J, Nardelli DT, Warner TF, et al. (2011). Interleukin-35 enhances Lyme arthritis in Borrelia-vaccinated and -infected mice. Clin Vaccine Immunol 18:1125-32.
58. Lauw FN, Caffrey DR, Golenbock DT. (2005). Of mice and man: TLR11 (finally) finds profilin. Trends Immunol 26:509-11.
59. Lee RT, Ichikawa Y, Allen HJ, Lee YC. (1990). Binding characteristics of galactoside-binding lectin (galaptin) from human spleen. J Biol Chem 265:7864-71.
60. Lien E, Sellati TJ, Yoshimura A, et al. (1999). Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J Biol Chem 274:33419-25.
61. Lin SC, Lo YC, Wu H. (2010). Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature 465:885-90.
62. Lisinski TJ, Furie MB. (2002). Interleukin-10 inhibits proinflammatory activation of endothelium in response to Borrelia burgdorferi or lipopolysaccharide but not interleukin-1beta or tumor necrosis factor alpha. J Leukoc Biol 72:503-11.
63. Liu N, Montgomery RR, Barthold SW, Bockenstedt LK. (2004). Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect Immun 72:3195-203.
64. Macdonald AB. (2013). Borrelia burgdorferi tissue morphologies and imaging methodologies. Eur J Clin Microbiol Infect Dis 32: 1077-82.
65. Mancuso G, Gambuzza M, Midiri A, et al. (2009). Bacterial recognition by TLR7 in the lysosomes of conventional dendritic cells. Nat Immunol 10:587-94.
66. Menten-Dedoyart C, Faccinetto C, Golovchenko M, et al. (2012). Neutrophil extracellular traps entrap and kill Borrelia burgdorferi sensu stricto spirochetes and are not affected by Ixodes ricinus tick saliva. J Immunol 189:5393-401.
67. Miller JC, Ma Y, Bian J, et al. (2008). A critical role for type I IFN in arthritis development following Borrelia burgdorferi infection of mice. J Immunol 181:8492-503.
68. Miller JC, Maylor-Hagen H, Ma Y, et al. (2010). The Lyme disease spirochete Borrelia burgdorferi utilizes multiple ligands, including RNA, for interferon regulatory factor 3-dependent induction of type I interferon-responsive genes. Infect Immun 78:3144-53.
69. Miller LC, Isa S, Vannier E, et al. (1992). Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist. J Clin Invest 90: 906-12.
70. Miller SC, Porcella SF, Raffel SJ, et al. (2013). Large linear plasmids of Borrelia species that cause relapsing fever. J Bacteriol 195: 3629-39.
71. Moore MW, Cruz AR, Lavake CJ, et al. (2007). Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production. Infect Immun 75:2046-62.
72. Mullegger RR, Means TK, Shin JJ, et al. (2007). Chemokine signatures in the skin disorders of Lyme borreliosis in Europe: predominance of CXCL9 and CXCL10 in erythema migrans and acrodermatitis and CXCL13 in lymphocytoma. Infect Immun 75:4621-8.
73. Nardelli DT, Luedtke JO, Munson EL, et al. (2010). Significant differences between the Borrelia-infection and Borrelia-vaccination and -infection models of Lyme arthritis in C3H/HeN mice. FEMS Immunol Med Microbiol 60:78-89.
74. Oliveira-Nascimento L, Massari P, Wetzler LM. (2012). The role of TLR2 in infection and immunity. Front Immunol 3:79.
75. Olson CM, Juan Anguita EF. (2013). Clinical immunology.
76. Onder O, Humphrey PT, Mcomber B, et al. (2012). OspC is a potent plasminogen-receptor on the surface of Borrelia burgdorferi. J. Biol. Chem 287:16860-8.
77. Oosting M, Berende A, Sturm P, et al. (2010). Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction. J Infect Dis 201:1849-58.
78. Oosting M, Buffen K, Malireddi SR, et al. (2012). Murine Borrelia arthritis is highly dependent on ASC and caspase-1, but independent of NLRP3. Arthritis Res Ther 14:R247.
79. Oosting M, Ter HH, Sturm P, et al. (2011a). TLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes. PLoS One 6:e25998.
80. Oosting M, ter Hofstede H, Van de Veerdonk FL, et al. (2011b). Role of interleukin-23 (IL-23) receptor signaling for IL-17 responses in human Lyme disease. Infect Immun 79:4681-7.
81. Oosting M, Van de Veerdonk FL, Kanneganti TD, et al. (2011c). Borrelia species induce inflammasome activation and IL-17 production through a caspase-1-dependent mechanism. Eur J Immunol 41: 172-81.
82. Papadopoulos AI, Ferwerda B, Antoniadou A, et al. (2012). Association of Mal/TIRAP S180L variant polymorphism with decreased infection risk in patients with advanced HIV-1 infection. Cytokine 60:104-7.
83. Peterson PK, Clawson CC, Lee DA, et al. (1984). Human phagocyte interactions with the Lyme disease spirochete. Infect Immun 46: 608-11.
84. Petnicki-Ocwieja T, Defrancesco AS, Chung E, et al. (2011). Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance. PLoS One 6: e17414.
85. Petzke MM, Brooks A, Krupna MA, et al. (2009). Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells. J Immunol 183:5279-92.
86. Picard C, Casanova JL, Puel A. (2011). Infectious diseases in patients with IRAK-4, MyD88, NEMO, or Ikappa Balpha deficiency. Clin Microbiol Rev 24:490-7.
87. Pietikainen J, Meri T, Blom AM, Meri S. (2010). Binding of the complement inhibitor C4b-binding protein to Lyme disease Borreliae. Mol Immunol 47:1299-305.
88. Porat R, Poutsiaka DD, Miller LC, et al. (1992). Interleukin-1 (IL-1) receptor blockade reduces endotoxin and Borrelia burgdorferi-stimulated IL-8 synthesis in human mononuclear cells. FASEB J 6: 2482-6.
89. Pugin J, Heumann ID, Tomasz A, et al. (1994). CD14 is a pattern recognition receptor. Immunity 1:509-16.
90. Radolf JD, Caimano MJ, Stevenson B, Hu LT. (2012). Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol 10:87-99.
91. Reid DM, Gow NA, Brown GD. (2009). Pattern recognition: recent insights from Dectin-1. Curr Opin Immunol 21:30-7.
92. Robinson MJ, Osorio F, Rosas M, et al. (2009). Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection. J Exp Med 206:2037-51.
93. Rosentul DC, Plantinga TS, Oosting M, et al. (2011). Genetic variation in the dectin-1/CARD9 recognition pathway and susceptibility to candidemia. J Infect Dis 204:1138-45.
94. Sahay B, Patsey RL, Eggers CH, et al. (2009). CD14 signaling restrains chronic inflammation through induction of p38-MAPK/SOCSdependent tolerance. PLoS Pathog 5:e1000687.
95. Sahay B, Singh A, Gnanamani A, et al. (2011). CD14 signaling reciprocally controls collagen deposition and turnover to regulate the development of Lyme arthritis. Am J Pathol 178:724-34.
96. Salazar JC, Duhnam-Ems S, La VC, et al. (2009). Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta. PLoS Pathog 5:e1000444.
97. Salazar JC, Pope CD, Moore MW, et al. (2005). Lipoprotein-dependent and -independent immune responses to spirochetal infection. Clin Diagn Lab Immunol 12:949-58.
98. Schroder K, Tschopp J. (2010). The inflammasomes. Cell 140:821-32.
99. Schuijt TJ, Coumou J, Narasimhan S, et al. (2011). A tick mannosebinding lectin inhibitor interferes with the vertebrate complement cascade to enhance transmission of the lyme disease agent. Cell Host Microbe 10:136-46.
100. Schuijt TJ, Hovius JW, Van Burgel ND, et al. (2008). The tick salivary protein Salp15 inhibits the killing of serum-sensitive Borrelia burgdorferi sensu lato isolates. Infect Immun 76:2888-94.
101. Sellati TJ, Bouis DA, Kitchens RL, et al. (1998). Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides activate monocytic cells via a CD14-dependent pathway distinct from that used by lipopolysaccharide. J Immunol 160:5455-64.
102. Shin JJ, Glickstein LJ, Steere AC. (2007). High levels of inflammatory chemokines and cytokines in joint fluid and synovial tissue throughout the course of antibiotic-refractory lyme arthritis. Arthritis Rheum 56: 1325-35.
103. Shin OS, Isberg RR, Akira S, et al. (2008). Distinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine induction. Infect Immun 76:2341-51.
104. Shin OS, Miller LS, Modlin RL, et al. (2009). Downstream signals for MyD88-mediated phagocytosis of Borrelia burgdorferi can be initiated by TRIF and are dependent on PI3K. J Immunol 183:491-8.
105. Siegel C, Hallstrom T, Skerka C, et al. (2010). Complement factor Hrelated proteins CFHR2 and CFHR5 represent novel ligands for the infection-associated CRASP proteins of Borrelia burgdorferi. PLoS One 5:e13519.
106. Sonderegger FL, Ma Y, Maylor-Hagan H, et al. (2012). Localized production of IL-10 suppresses early inflammatory cell infiltration and subsequent development of IFN-gamma-mediated Lyme arthritis. J Immunol 188:1381-93.
107. Steere AC, Coburn J, Glickstein L. (2004). The emergence of Lyme disease. J Clin Invest 113:1093-101.
108. Steere AC, Malawista SE, Snydman DR, et al. (1977). Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities. Arthritis Rheum 20:7-17.
109. Stewart PE, Byram R, Grimm D, et al. (2005). The plasmids of Borrelia burgdorferi: essential genetic elements of a pathogen. Plasmid 53: 1-13.
110. Strle K, Drouin EE, Shen S, et al. (2009). Borrelia burgdorferi stimulates macrophages to secrete higher levels of cytokines and chemokines than Borrelia afzelii or Borrelia garinii. J Infect Dis 200:1936-43.
111. Strle K, Jones KL, Drouin EE, et al. (2011). Borrelia burgdorferi RST1 (OspC type A) genotype is associated with greater inflammation and more severe Lyme disease. Am J Pathol 178:2726-39.
112. Strle K, Shin JJ, Glickstein LJ, Steere AC. (2012). Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis. Arthritis Rheum 64:1497-507.
113. Stubs G, Fingerle V, Zahringer U, et al. (2011). Acylated cholesteryl galactosides are ubiquitous glycolipid antigens among Borrelia burgdorferi sensu lato. FEMS Immunol Med Microbiol 63:140-3.
114. Suhonen J, Hartiala K, Tuominen-Gustafsson H, Viljanen MK. (2000). Borrelia burgdorferi-induced oxidative burst, calcium mobilization, and phagocytosis of human neutrophils are complement dependent. J Infect Dis 181:195-202.
115. Takayama K, Rothenberg RJ, Barbour AG. (1987). Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi. Infect Immun 55:2311-13.
116. Takeuchi O, Kawai T, Muhlradt PF, et al. (2001). Discrimination of bacterial lipoproteins by Toll-like receptor 6. Int Immunol 13:933-40.
117. Takeuchi O, Sato S, Horiuchi T, et al. (2002). Cutting edge: role of Tolllike receptor 1 in mediating immune response to microbial lipoproteins. J Immunol 169:10-14.
118. Van Dam AP, Oei A, Jaspars R, et al. (1997). Complement-mediated serum sensitivity among spirochetes that cause Lyme disease. Infect Immun 65:1228-36.
119. Vautier S, Sousa MG, Brown GD. (2010). C-type lectins, fungi and Th17 responses. Cytokine Growth Factor Rev 21:405-12.
120. Wang X, Ma Y, Yoder A, et al. (2008). T cell infiltration is associated with increased Lyme arthritis in TLR2-/- mice. FEMS Immunol Med Microbiol 52:124-33.
121. Widhe M, Jarefors S, Ekerfelt C, et al. (2004). Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J Infect Dis 189:1881-91.
122. Wooten RM, Ma Y, Yoder RA, et al. (2002). Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J Immunol 168:348-55.
123. Yoneyama M, Kikuchi M, Matsumoto K, et al. (2005). Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol 175:2851-8.